Published on
December 10, 2025
- 06:18 GMT
Cancer’s 'Dark Matter' Outshines Neoantigens in Landmark Debate
A First-in-Class Cancer Vaccine Built From Human “Dark Genome” Just Beat Neoantigens In Scientific Showdown and Showed Improved Survival In Head & Neck Cancer NAPLES, CAMPANIA, ITALY, December 10, 2025 /EINPresswire.com/ -- UbiVac, a private …
Distribution channels:
Aviation & Aerospace Industry, Banking, Finance & Investment Industry
...
